GlobeNewswire
-
300 Exceptional Teen Scientists Recognized for Innovative STEM Research in Nation’s Oldest and Most Prestigious High School Competition
07/01/2026 -
AB Science reports fourth consecutive case of response from Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
07/01/2026 -
AB Science annonce un quatrième cas consécutif de réponse avec la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute, sur la base des données de phase 1
07/01/2026 -
Comprehensive Healthcare Welcomes Community Behavioral Health Veteran as Chief Medical Officer
07/01/2026 -
GENFIT Announces 2026 Financial Calendar
07/01/2026 -
GENFIT annonce son calendrier financier pour 2026
07/01/2026 -
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering
07/01/2026 -
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
07/01/2026 -
Best Peptides for Weight Loss 2026: Oral Wegovy Launch Expands GLP-1 Format Options as Telehealth Platforms Compare FDA-Approved vs Compounded Semaglutide Access
07/01/2026 -
Ascentage Pharma Announces IND Clearance by the U.S. Food and Drug Administration for BTK Degrader APG-3288
07/01/2026 -
HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
07/01/2026 -
Propr® Launches Clinically Inspired Toothbrush Designed to Protect Teeth, Heal Gums, and Redefine Daily Oral Care
07/01/2026 -
TeamBest Global Celebrates 16 Years of Cyclotron Innovation and Its Role in the Future of Theranostics
06/01/2026 -
Dentsply Sirona to Present at the 44th Annual J.P. Morgan Healthcare Conference
06/01/2026 -
Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference
06/01/2026 -
ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
06/01/2026 -
Alumis Announces Proposed Public Offering of Common Stock
06/01/2026 -
OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
06/01/2026 -
Monte Rosa Therapeutics to Present Interim MRT-8102 Phase 1 Study Results
06/01/2026
Pages